Würzburg Childcare Study during the COVID-19 pandemic: A study into the acceptance of different screening measures for the detection of infections with the novel coronavirus (SARS-CoV-2) in child daycare centres in Würzburg
Not Applicable
- Conditions
- SARS-CoV-2-infection
- Registration Number
- DRKS00023721
- Lead Sponsor
- niversität Würzburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 592
Inclusion Criteria
Modules for surveillance of asymptomatic daycare children and staff: daycare children up to 8 years in participating daycare centres or staff employed in participating daycare centre;
For collection of saliva samples children of 2 years of age and older at study start were included.
Modules for surveillance of symptomatic participants: daycare children or staff in participating daycare centres and corresponding household member
Written consent of parents/guardians and daycare staff to participation in the study
Exclusion Criteria
/
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of acceptance rates of various surveillance measures for the detection of SARS-CoV-2 infections in daycare children, staff, and their household members; detection of SARS-CoV-2 infections via PCR from nasal swaps or saliva samples from daycare children and staff; for household members from throat swaps;<br><br>Evaluation based on successful participation in all planned samplings during the study period; additionally, survey of parents/guardians, daycare staff and children at defined time points for the collection of sociodemographic data and psychosocial implications, including determination of predictors for the acceptance of the different concepts.
- Secondary Outcome Measures
Name Time Method Collection of basic data of SARS-CoV-2 seroprevalence and the number of SARS-CoV-2 infections in daycare children and staff in Würzburg (point-of-care-test via finger-prick testing or ELISA from serum; rate of positive serological tests and positive PCR tests);<br><br>Estimation of the costs of the surveillance measures.